SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-21-022519
Filing Date
2021-04-30
Accepted
2021-04-30 16:03:11
Documents
14
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A sndx-10ka_20201231.htm   iXBRL 10-K/A 213747
2 EX-31.1 sndx-ex311_24.htm EX-31.1 11788
3 EX-31.2 sndx-ex312_25.htm EX-31.2 11802
  Complete submission text file 0001564590-21-022519.txt   451206

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sndx-20201231.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20201231_lab.xml EX-101.LAB 30775
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20201231_pre.xml EX-101.PRE 18460
7 EXTRACTED XBRL INSTANCE DOCUMENT sndx-10ka_20201231_htm.xml XML 8290
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37708 | Film No.: 21877725
SIC: 2834 Pharmaceutical Preparations